Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V R Peddi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Transplantation|December 10, 1997
Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejectionS Kamath, D Dean, V R Peddi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 19, 1998
Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registryS Hariharan, V R Peddi, V J Savin, et al.
Clinical Transplantation|June 1, 1997
Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine eraJ F Valente, S Hariharan, V R Peddi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 25, 2016
Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month DataY Qazi, D Shaffer, B Kaplan, et al.
Transplantation|January 28, 2003
MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literatureMeredith J Aull, Joseph F Buell, V R Peddi, et al.
Transplantation|October 3, 1999
Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR)S Hariharan, M B Adams, D C Brennan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2009
Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipientsS Busque, J Leventhal, D C Brennan, et al.
Transplantation Proceedings|April 14, 2019
Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical PracticeM R First, V R Peddi, R Mannon, et al.
Transplantation Proceedings|April 14, 2019
Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal FunctionC L Marsh, S M Kurian, J C Rice, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Transplantation|December 10, 1997
Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejectionS Kamath, D Dean, V R Peddi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 19, 1998
Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registryS Hariharan, V R Peddi, V J Savin, et al.
Clinical Transplantation|June 1, 1997
Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine eraJ F Valente, S Hariharan, V R Peddi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 25, 2016
Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month DataY Qazi, D Shaffer, B Kaplan, et al.
Transplantation|January 28, 2003
MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literatureMeredith J Aull, Joseph F Buell, V R Peddi, et al.
Transplantation|October 3, 1999
Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR)S Hariharan, M B Adams, D C Brennan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2009
Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipientsS Busque, J Leventhal, D C Brennan, et al.
Transplantation Proceedings|April 14, 2019
Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical PracticeM R First, V R Peddi, R Mannon, et al.
Transplantation Proceedings|April 14, 2019
Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal FunctionC L Marsh, S M Kurian, J C Rice, et al.
Pageof 2